57332-78-2 Usage
General Description
Ethyl 5-methyl-2-sulfanylidene-1,3-dihydroimidazole-4-carboxylate is a chemical compound with the molecular formula C8H11N3O2S. It is a derivative of imidazole and contains an ethyl ester group. ethyl 5-methyl-2-sulfanylidene-1,3-dihydroimidazole-4-carboxylate has potential applications in pharmaceuticals and agrochemicals due to its heterocyclic structure and sulfur-containing functional group. The presence of the ethyl ester group makes it useful in organic synthesis and as a building block for the preparation of more complex molecules. Additionally, its sulfur-containing moiety may also impart some interesting chemical properties, making it of interest for further research and development. Overall, ethyl 5-methyl-2-sulfanylidene-1,3-dihydroimidazole-4-carboxylate has potential applications in various fields and its properties make it an interesting compound for further study.
Check Digit Verification of cas no
The CAS Registry Mumber 57332-78-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,3,3 and 2 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 57332-78:
(7*5)+(6*7)+(5*3)+(4*3)+(3*2)+(2*7)+(1*8)=132
132 % 10 = 2
So 57332-78-2 is a valid CAS Registry Number.
InChI:InChI=1/C7H10N2O2S/c1-3-11-6(10)5-4(2)8-7(12)9-5/h3H2,1-2H3,(H2,8,9,12)
57332-78-2Relevant articles and documents
3-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES
-
Page/Page column 41, (2010/02/17)
The invention relates to 3-aza-bicyclo[3.1.0]hexane derivatives of formula (I) wherein A, B, n, X, and R1 are as described in the description, and salts thereof, and their use as orexin receptor antagonists.
2-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES
-
Page/Page column 66-67, (2008/12/07)
The invention relates to novel 2-aza-bicyclo[3.1.0]hexane derivatives of Formula (I) wherein A, B, n and R1 are as described in the description, and to the use of such compounds, or of pharmaceutically acceptable salts of such compounds, as medicaments, especially as orexin receptor antagonists.